This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (3)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

N. A. GETZLER, M.D.; WILLIAM LINTON, M.D.; A. T. JEGYUD, M.D.

Arch Dermatol. 1961;84(3):439-443.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Cutaneous tuberculosis has become a rarity on this continent, while its incidence is still considerable in many parts of the world. Tanimura and Sano¹ list the incidence of tuberculosis of the skin as 1.2% of all skin diseases registered at the University outdoor clinics of Osaka in Japan. Gnuzdev² reported 118 cases of cutaneous tuberculosis treated since 1952 in European Russia, using streptomycin, isoniazid, and PAS. Riehl and Lofferer³ reported 54% cure in 1949, while 84% responded favorably in 1957, and attributed this therapeutic improvement to the use of isoniazid preparations. They claim that INH alone is superior to its combination with streptomycin and PAS. Marchionini and Roeckl⁴ and Kiming Schulz⁵ came to similar conclusions.

The following case of cutaneous tuberculosis appears of interest because of its long duration and its extent and because an unusual type of Mycobacterium appeared to be the causative organism . . . [Full Text PDF of this Article]

Author Affiliations
MONTREAL

From the Department of Medicine, Subdepartment of Dermatology of the Royal Victoria Hospital, and the Royal Edward Laurentian Hospital of Montreal.

Footnotes
Submitted for publication April 17, 1961.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?